Anders has extensive experience as an executive in the biopharmaceutical industry and is currently a Chairman or Non-executive board member of several public and private biotech companies. Anders was previously Chairman of the Board at Karolinska University Hospital and now serves on the Board for the Swedish Research Council. During two decades at AstraZeneca, he was a member of global executive teams including Executive VP Global Medicines Development, Global Head Clinical Development, Global Therapy Area Head, Global Head Science & Technology Integration, and CEO AstraZeneca AB Sweden. Anders is also a board-certified MD (Anaesthesiology and Intensive Care), Ph.D., DDS, and Associate Professor at Karolinska Institute, Stockholm, Sweden, and a fellow of the Royal Swedish Academy of Engineering Sciences.